Evidence map›Paper›PMID 35577986›Full record

ArticleArchives of toxicology2022

rVSV-ΔG-SARS-CoV-2-S vaccine: repeated intramuscular (IM) toxicity, local tolerance, immunogenicity and biodistribution study in NZW rabbits.

Amir Rosner, Michal Steiner, Sharon Melamed, Boaz Politi, Einat Vitner, Hadas Tamir, Hagit Achdout, Lilach Cherry, Roy Avraham, Yfat Yahalom-Ronen and 15 more

Open access · bronzeAbstract read
In one paragraph

Article in Archives of toxicology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors at 2 institutions in 1 country.

Amir Rosner *Veterinary Center for Preclinical Research, Israel Institute for Biological Research, Ness-Ziona, Israel.
Michal Steiner *Gsap, Matam Building 22, Haifa, Israel.
Sharon MelamedDepartment of Infectious Diseases, Israel Institute for Biological Research, Ness Ziona, Israel.
Boaz PolitiDepartment of Infectious Diseases, Israel Institute for Biological Research, Ness Ziona, Israel.
Einat VitnerDepartment of Infectious Diseases, Israel Institute for Biological Research, Ness Ziona, Israel.
Hadas TamirDepartment of Infectious Diseases, Israel Institute for Biological Research, Ness Ziona, Israel.
Hagit AchdoutDepartment of Infectious Diseases, Israel Institute for Biological Research, Ness Ziona, Israel.
Lilach CherryDepartment of Biotechnology, Israel Institute for Biological Research, Ness Ziona, Israel.
Roy AvrahamDepartment of Infectious Diseases, Israel Institute for Biological Research, Ness Ziona, Israel.
Yfat Yahalom-RonenDepartment of Infectious Diseases, Israel Institute for Biological Research, Ness Ziona, Israel.
Haim LevyDepartment of Infectious Diseases, Israel Institute for Biological Research, Ness Ziona, Israel.
Adi Beth-DinDepartment of Biochemistry and Molecular Genetics, Israel Institute for Biological Research, Ness Ziona, Israel.
Dana SteinDepartment of Biochemistry and Molecular Genetics, Israel Institute for Biological Research, Ness Ziona, Israel.
Adva MechalyDepartment of Infectious Diseases, Israel Institute for Biological Research, Ness Ziona, Israel.
Morly FisherDepartment of Infectious Diseases, Israel Institute for Biological Research, Ness Ziona, Israel.
Ella FatelevichDepartment of Infectious Diseases, Israel Institute for Biological Research, Ness Ziona, Israel.
Shay WeissDepartment of Infectious Diseases, Israel Institute for Biological Research, Ness Ziona, Israel.
Noam KronfeldEnvigo CRS Israel Limited, Ness-Ziona, Israel.
Liora Madar-ShapiroIsrael Institute for Biological Research, Ness Ziona, Israel.
Abraham NyskaSackler School of Medicine, Tel Aviv University, and Consultant in Toxicologic Pathology, Tel Aviv, Israel.
Shmuel YitzhakiIsrael Institute for Biological Research, Ness Ziona, Israel.
Nir ParanDepartment of Infectious Diseases, Israel Institute for Biological Research, Ness Ziona, Israel.
Tomer IsraelyDepartment of Infectious Diseases, Israel Institute for Biological Research, Ness Ziona, Israel.
Hadar MarcusDepartment of Biotechnology, Israel Institute for Biological Research, Ness Ziona, Israel. hadarm@iibr.gov.il.ORCID 0000-0002-3934-6493
Noa Madar-BalakirskiDepartment of Pharmacology, Israel Institute for Biological Research, Ness Ziona, Israel. noa.madar@gmail.com.
Israel Institute for Biological Research · ILTel Aviv University · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BriLife

Indexed as

COVID-19COVID-19 VaccinesAnimalsAntibodies, NeutralizingAntibodies, ViralRabbitsSARS-CoV-2Tissue DistributionAntibodies, NeutralizingAntibodies, ViralCOVID-19 VaccinesCOVID-19Neutralizing antibodiesNonclinicalSafetyVaccine

Identifiers

PMID35577986
PMCPMC9110212
OpenAlexW4280550997

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.